Atlas Trials

Fatty Liver Disease, Nonalcoholic

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Fatty Liver Disease, Nonalcoholic

RecordFirmDate
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy (NCT01679197)University of Michigan2012-10-08
Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH) (NCT00596934)Elif Oral2006-02-01

Track Fatty Liver Disease, Nonalcoholic automatically

Every clearance here is in the API, with alerts when new ones post.